Clin2
NCT07363395Likely a fitRecruiting

A study of ASCT-83 in healthy adults

Neuropathic Pain

Part of Brain & nervous system, Injuries & trauma, Pain clinical trials.

This trial tests a new medication called ASCT-83 in healthy adults to see how safe it is and how the body processes it. It may help researchers understand the right dose for future studies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
72 people
Ages
18 years to 64 years
Study type
Interventional

Who can take part

  • You are between 18 and 64 years old.
  • You are generally healthy, based on your medical history, a physical exam, and lab tests.
  • Your body mass index (BMI) is between 19 and 35 at the screening visit.
  • If you are able to become pregnant, you agree to use birth control and have pregnancy tests during the study.
  • If you are male, you agree to use birth control and not donate sperm during the study.
  • You do not have any serious health conditions like heart, liver, kidney, immune, or autoimmune diseases.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05968664Recruiting
Test whether new spinal cord stimulation settings improve chronic pain

This trial studies whether changing the “stimulation pattern” of spinal cord stimulation can reduce long-lasting pain and improve daily function. You might be a good candidate if you have chronic trunk or leg pain and have already tried multiple pain treatments without enough relief.

Houston, Texas
NCT06438471Recruiting· Phase 1
Study of a new drug for nerve pain after spinal cord injury

This trial tests an experimental pill for people with spinal cord injury who have long-term nerve pain. It aims to see if the drug can reduce pain and be safe.

Augusta, Georgia
NCT07618247Not yet recruiting· Phase 1
Testing a new drug in healthy adults

This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.

Adelaide, South Australia
NCT07335913Recruiting· Phase 1
Testing SBS-147 in healthy adults for safety

This study tests a new drug, SBS-147, in healthy adults to see if it's safe and how the body processes it. It may help find the right dose for future studies in people with certain conditions.

Cypress, California
NCT07463196Recruiting· Phase 1
Safety study of ACI-19764 in healthy adults

This trial tests a new oral medication, ACI-19764, in healthy adults to see how safe it is and how the body processes it. It may help researchers understand how the drug affects the immune system, which could lead to future treatments for certain conditions.

Groningen
NCT07752472Not yet recruiting· Phase 1
Study of PSTC100 in healthy adults

This study tests a new medicine called PSTC100 in healthy adults to see if it is safe and how the body handles it. It is a Phase 1 trial, which means the medicine is still early in testing, and your participation could help find out if it might help people with certain conditions later.

Saint Leonards, New South Wales

Hear when a new Neuropathic Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.